The agency has reviewed reports of cancer patients whose treatments resulted in the development of secondary blood cancers. Several companies will be required to carry the new warning.
from NYT > Health https://ift.tt/dbpltLF
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment